Search

everythinglearnresearchcommunity

for

Search:↓

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Stopping nalfurafine reversed hair loss in a hemodialysis patient.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Afatinib often causes skin problems that need proactive management.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.